Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Filgotinib: First Approval
2020
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Polycystic ovary syndrome
2016 Standout
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
2015
Alzheimer's disease drug development pipeline: 2018
2018
Works of Lien Gheyle being referenced
Abstract 18403: Effect of Dabigatran on the Ability to Generate Fibrin at a Wound site and its Reversal by Idarucizumab, the Antidote to Dabigatran, in Healthy Volunteers: An Exploratory Marker of Blood Loss
2014
FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR)
2020
The NK3 Receptor Antagonist ESN364 Suppresses Sex Hormones in Men and Women
2015
FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2)
2020
A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
2017